Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,285 | 25,998 | 26,504 | 61,641 | 0 |
| Marketable Securities | 87,065 | 115,822 | 124,756 | 12,022 | 0 |
| TOTAL | $129,207 | $144,768 | $154,554 | $74,137 | $0 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4,022 | 2,707 | 2,471 | 3,370 | 0 |
| TOTAL | $4,022 | $2,707 | $2,471 | $3,370 | $N/A |
| Total Assets | $133,229 | $147,475 | $157,025 | $77,507 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,444 | 5,056 | 2,556 | 2,298 | 0 |
| Accrued Expenses | 5,863 | 4,837 | 3,030 | 2,291 | 0 |
| TOTAL | $10,736 | $10,310 | $5,976 | $4,927 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 116 | 240 | 360 | 467 | 0 |
| TOTAL | $116 | $240 | $360 | $467 | $N/A |
| Total Liabilities | $10,852 | $10,550 | $6,336 | $5,394 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,773 | 21,697 | 21,696 | N/A | N/A |
| Retained earnings | -98,320 | -82,004 | -67,637 | -58,327 | 0 |
| Other shareholders' equity | 82 | -3 | 44 | 126,756 | 0 |
| TOTAL | $122,377 | $136,925 | $150,689 | $72,113 | $0 |
| Total Liabilities And Equity | $133,229 | $147,475 | $157,025 | $77,507 | $0 |